131 related articles for article (PubMed ID: 29367412)
1. "Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice." Stephen Y. Chan and Lewis J. Rubin.
Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367412
[No Abstract] [Full Text] [Related]
2. "Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension." Catherine E. Simpson, Jenny Y. Chen, Rachel L. Damico,
Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35484798
[No Abstract] [Full Text] [Related]
3. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
Eur Respir Rev; 2016 Mar; 25(139):99. PubMed ID: 26929428
[No Abstract] [Full Text] [Related]
4. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang, Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28049123
[No Abstract] [Full Text] [Related]
5. "Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension." Irene Lang, Bernhard C. Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer and Philippe Brenot.
Eur Respir Rev; 2017 Jun; 26(144):. PubMed ID: 28615306
[No Abstract] [Full Text] [Related]
6. "Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms." S. Malenfant, M. Lebret, É. Breton-Gagnon,
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38355152
[TBL] [Abstract][Full Text] [Related]
7. Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling.
Finlay WH; Stapleton KW; Chan HK; Zuberbuhler P; Gonda I
J Appl Physiol (1985); 1996 Jul; 81(1):374-83. PubMed ID: 8828688
[TBL] [Abstract][Full Text] [Related]
8. "Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?" Irene M. Lang and Hiromi Matsubara.
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31649150
[No Abstract] [Full Text] [Related]
9. "Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis." Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58-64.
Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324819
[No Abstract] [Full Text] [Related]
10. "Cellular mechanisms underlying steroid-resistant asthma." Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro.
Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722895
[No Abstract] [Full Text] [Related]
11. "Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing." Denis E. O'Donnell, Amany F. Elbehairy, Azmy Faisal, Katherine A. Webb, J. Alberto Neder and Donald A. Mahler. Eur Respir Rev 2016; 25: 333-347.
Eur Respir Rev; 2016 Dec; 25(142):513. PubMed ID: 27903672
[No Abstract] [Full Text] [Related]
12. "Immune mechanisms in fibrotic pulmonary sarcoidosis". P. Weeratunga, D.R. Moller and L-P. Ho.
Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37611949
[No Abstract] [Full Text] [Related]
13. "Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis." Bridget F. Collins and Ganesh Raghu.
Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722893
[No Abstract] [Full Text] [Related]
14. "The therapy of idiopathic pulmonary fibrosis: what is next?" Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi,
Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31554706
[No Abstract] [Full Text] [Related]
15. "Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis." Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown.
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29653947
[No Abstract] [Full Text] [Related]
16. "Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats." R. Dumitrascu, C. Kulcke, M. Königshoff,
Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34916252
[No Abstract] [Full Text] [Related]
17. "Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis." M. Kolb, B. Crestani and T.M. Maher.
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38537950
[No Abstract] [Full Text] [Related]
18. "The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment." Silvia Ulrich and Ekkehard Grunig.
Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 33767003
[No Abstract] [Full Text] [Related]
19. "Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension." Mark Toshner, Colin Church, Lars Harbaum,
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 35798371
[No Abstract] [Full Text] [Related]
20. Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.
Kumar S; Wei C; Thomas CM; Kim IK; Seqqat R; Kumar R; Baker KM; Jones WK; Gupta S
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1655-66. PubMed ID: 22245771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
